Presentation TCT 2025 TCT 975: Impact of Impella 5.5 on Renal Function: A Systematic Review and Meta-Analysis of Creatinine Improvement in Cardiogenic Shock Presenter: Vasishtha Upadrasta October 27, 2025
Presentation TCT 2025 TCT 546: Real-World Clinical Outcomes Using Bicarbonate Purge Solution during Impella 5.5 Support: A Data Linkage Analysis Presenter: Ahmad Zeeshan October 27, 2025
Presentation TCT 2025 TCT 281: Gender Disparities in Outcomes of Impella Use in Acute Myocardial Infarction Complicated by Cardiogenic Shock Presenter: Junaid Mir October 27, 2025
Presentation TCT 2025 TCT 1650: Adapting SHiP Technique With Impella 5.5 for Post-Surgical Shock and Managing Graft Kinking From Drain Compression Presenter: Christina Mansour October 25, 2025
Presentation THT 2025 Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry Presenter: Jacob Abraham February 12, 2025
Presentation THT 2025 Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5 Presenter: Kanika Mody February 12, 2025
Presentation THT 2025 Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD Presenter: Katherine Wood February 12, 2025
Presentation THT Abstracts 2025 Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function Presenter: Gabrielle Daso February 11, 2025
Presentation THT Abstracts 2025 Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5 February 11, 2025
Presentation THT Abstracts 2025 Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5 Presenter: Alexis Barnes February 11, 2025
Presentation THT 2025 Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis Presenter: Anthony Carnicelli February 11, 2025
Presentation THT 2025 Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5 Presenter: Alexis Barnes February 11, 2025
Presentation THT 2025 Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function Presenter: Gabrielle Daso February 11, 2025
Presentation THT 2025 Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs Presenter: Anthony Carnicelli February 11, 2025
Presentation THT 2025 Impella 5.5: A GameChanger for Cardiogenic Shock Presenter: Jerome Crowley February 11, 2025
Presentation TCT 2024 TCT 585: Impella CP and 5.5 Device Flows Are Overestimated by the SmartAssist Automated Impella Controller (AIC) Presenter: Christian Said October 30, 2024
Presentation TCT 2024 TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5 Presenter: Shashank Sinha October 29, 2024
Presentation TCT 2024 Debate Pro: Keep P8 Impella 5.5 (de-escalate VA) as Bridge to Recovery Presenter: Amirali Masoumi October 29, 2024
Presentation TCT 2024 TCT 582: Evaluation of LVEDP Change During High-Risk PCI With and Without Impella Support (ELVIS): A Pilot Trial Presenter: Juergen Leick October 28, 2024
Presentation TCT 2024 TCT 576: The Impact of Atherectomy in Severely Calcified Lesions in Patients With Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study Presenter: Batla Falah October 28, 2024